key: cord-1031404-gm1si1gi
authors: Rigante, Donato
title: Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection
date: 2020-07-01
journal: Mediterr J Hematol Infect Dis
DOI: 10.4084/mjhid.2020.039
sha: dbdc445baa900935bee5ca99dc48b48c0e38e6b7
doc_id: 1031404
cord_uid: gm1si1gi

Although the etiology of Kawasaki disease (KD) remains elusive, the available evidence indicates that the primum movens may be a dysregulated immune response to various microbial agents, leading to cytokine cascade and endothelial cell activation in patients with KD. Documented infections by different viruses in many individual cases have been largely reported and are discussed herein, but attempts to demonstrate their causative role in the distinctive KD scenario and KD epidemiological features have been disappointing. To date, no definite link has been irrefutably found between a single infection and KD.

Disease. In plain terms, KD is a systemic vasculitis that mainly and typically occurs in infants and children less than five years: the most ominous complication of patients with KD is the occurrence of coronary artery abnormalities (CAA). 3 For this reason, KD is actually the leading cause of acquired pediatric heart disease in the developed world. 4 Many reports found that coronary arteritis occurred at the highest incidence, but that vasculitis developed at various sites throughout the body. Vascular lesions of KD may start in the tunica interna and externa of medium-sized muscular arteries, such as the coronary arteries, but also in arterioles, venules and capillaries, while inflammation disseminates to large arteries including the coronary arteries. 5, 6 The media of affected vessels demonstrates edematous dissociation of the smooth muscle cells, while endothelial cell swelling and subendothelial edema are seen. An influx of neutrophils can be observed in the early stages of KD, with a rapid transition to large mononuclear cells in concert with lymphocytes and IgA plasma cells. Destruction of the internal elastic lamina and an eventual fibroblast proliferation can occur later. This active inflammation is replaced over several weeks to months by progressive fibrosis, with scar formation and remodeling. 7

The Clinical Chameleon of Kawasaki Disease. The classic diagnosis of KD has been historically based on the presence of 5 days of fever and a typical constellation of nonspecific clinical signs described in 1967 by dr. Kawasaki: upholding the diagnosis of KD requires that highly swinging fever is combined with at least 4 out of 5 "main" clinical features: [a] bilateral nonexudative conjunctivitis, [b] unilateral cervical lymphadenopathy, [c] polymorphous rash, [d] changes in the extremities (mainly in the form of angioedema) or in the perineal region (an early-onset desquamating rash) and [e] changes in the lips and/or oral cavity (dry fissured or reddened lips with a strawberry-like tongue). 8 Although the clinical clues of KD are easily recognizable, its underlying mechanisms are under deep investigation and remain poorly understood. Treatment of KD requires intravenous immunoglobulin (IVIG) and aspirin during the first ten days of illness, and its ultimate goal is avoiding the occurrence of CAA. 9 Mostly in the case of resistance to IVIG, inflammatory cells reach the vasa vasorum of coronary arteries with the risk of fragmentation of the internal lamina and damage to the media, resulting in the formation of CAA. 10 Higher values of C-reactive protein and younger age at onset are crucial points in determining respectively a failure in response to IVIG and a higher risk that the disease could be complicated by CAA. 11 Early ascertainment of non-responders to IVIG who might require additional therapies reducing the development of CAA is still a challenge. 12 With improved treatment methods and different drugs useful for refractory cases, the mortality rate of KD has dropped dramatically in recent years. However, despite increased awareness, the number of patients with KD presenting with incomplete or atypical features is increasing across the world. Incomplete cases of KD are characterized by less than four main clinical signs and atypical ones by a broad range of unusual clinical features, including aseptic meningitis, peripheral facial nerve palsy, liver impairment with jaundice, gallbladder hydrops, pneumonia-like disease, and even macrophage activation syndrome. 13, 14 Different Potential Causes, One Resulting Disease. Despite extensive research, the etiology of KD is far to be unraveled, and no single pathognomonic clinical or laboratory finding for diagnosis has been identified. Indeed, the occurrence of KD in epidemics, as shown by nationwide epidemiologic surveys conducted with biennial frequency since 1970, reveals a potential relationship of KD with an infectious disease. A number of infectious agents, both bacterial and viral, have been isolated from patients with KD through the years, 15 but also non-infectious triggers are presumed to cause the disease. 16 Further KD characteristics such as high-grade fever, elevated acute-phase reactants, and elevated white blood cell count strongly suggest an infectious cause, and in particular, some characteristics may suggest a viral etiology, such as the self-limited course of KD, skin rash and conjunctivitis. A host of reports have clarified the distinct seasonality of KD in geographically distinct regions of the northern hemisphere, revealing that various triggers may be operating at different times of the year in various geospatial clustering of KD cases: 17 the seasonality of KD, with winter peaks in Japan and winter-spring predominance in the USA or in many other temperate areas, is highly suggestive of a viral etiology. 18 Shimizu et al. found a seasonal effect also on the response to IVIG treatment, with more patients manifesting resistance to IVIG in the warm seasons from May to October, but no differences in the general outcome of CAA. 19 Several epidemiological studies have also demonstrated that KD is frequently associated with a previous respiratory illness; however, no differences have been found in children stratified according to positive or negative respiratory viral testing; in fact, a positive test for respiratory viruses at the time of presentation should not be used to exclude the diagnosis of KD. 20

Searching for papers dedicated to KD and published in the last 35 years through PubMed (matching the terms "KD" and "virus" or "viral infection"), a list of viral agents hypothetically associated with KD can be drawn (see Table 1 ). Viral respiratory infections have been commonly found at the diagnosis of KD, 21 but they do not seem to affect patients' response to IVIG or influence the overall outcome. 22 The oldest reports date back to 1983 when rotavirus was found in the feces of children with KD 23 and to 1985 when parainfluenza virus and adenovirus were encountered. 24,25 A molecular-based adenovirus detection is relatively frequent in KD patients but should be interpreted with caution. 26 Indeed, 24 out of 25 children with adenovirus disease mimicking features of KD had a higher viral burden compared to those with KD and incidental adenovirus detection. 27 Anecdotal reports had been associated KD to human herpesvirus-6, 39 and bocavirus are mostly isolated reports. 40 In particular for bocavirus, its nucleic acid was found in the nasopharyngeal, serum and stool samples from 5/16 (31.2%) patients with KD by reverse transcriptase-polymerase chain reaction (RT-PCR). 41 The Outbreak of the New Coronavirus and Kawasaki Disease. The latest outbreak of the new coronavirus (HCoV) infection (named SARS-CoV-2) and the resulting pandemic threat to health worldwide has required strict social containment measures since February 2020, but has also spread the suspicion that this peculiar infection might trigger KD. As a matter of fact, HCoV has been associated with many reports of KD in the past: for instance, in a prospective casecontrolled study among Taiwanese children it was isolated in 7.1% of cases. 47 In 2005 Esper et al. identified a novel human HCoV, named "New Haven," in the respiratory secretions from 8/11 children with KD. 48 However, in Denver (Colorado, USA) the prevalence of HCoV-NL63 infection was not higher in KD patients compared with non-KD controls. 49 The contribution of HCoV-229E infection in the development of KD was also brought in question by Shirato et al., who used immunofluorescence testing to detect virus-neutralizing antibodies in 15 patients with KD before IVIG treatment. 50 The first case of KD associated with a concomitant SARS-CoV-2 infection was a 6-month infant hospitalized in Palo Alto (California, USA). However, the clinical significance of patient's positive testing remained unclear in the setting of KD. 51 Furthermore, a 5-year-old Afro-American boy was found to have KD-related signs in Jackson (Mississippi, USA) in combination with severe acute respiratory distress and shock syndrome, referred to SARS-CoV-2 infection detected via RT-PCR from his nasopharyngeal swab. 52 In April 2020, Verdoni et al. reported a 30-fold increased incidence of KD-like syndrome in children living in the Bergamo province of Italy, after the SARS-CoV-2 epidemic began in that same area, also showing higher rates of heart involvement and general features of macrophage activation or shock syndrome. The evidence of contact with the virus was confirmed by the presence of antibodies against SARS-CoV-2 in 8 out of 10 reported patients. 53 This study had the limitation of being based on a small case series, but suggested indepth genetic analysis to investigate the potential susceptibility to KD after a triggering effect of SARS-CoV-2.

More recently, in the New York State (USA) during the period March-May 2020, a SARS-CoV-2-related multisystem inflammatory syndrome has been found in 95 patients younger than 21 years of all ethnic backgrounds: such patients presented an inflammatory vasculopathy showing some similarities to KD and toxic shock syndrome, and in particular nearly half of children 0 to 5 years, but only 12% of the adolescents 13 to 20 years of age had a discharge diagnosis of KD or atypical KD. 54 This study had the limitation of a presumed underestimation, possibly due to mild cases that did not require hospitalization.

Disease. Ultimately, viruses may be confounding bystanders in many descriptions of KD. However, intracytoplasmic inclusion bodies sharing morphologic features among several different RNA viral families have been found in autoptic tissues of patients deceased for KD. 55 Rowley et al. speculated that the development of KD could follow ubiquitous RNA viruses causing an asymptomatic infection or a very mild disease in the vast majority of children, but specifically "KD" in a subset of genetically selected people. 56 In addition, a pilot study investigating KD pathogenesis revealed specific viral signatures in 4/7 patients with KD via high-throughput sequencing on blood specimens, although 2 were corresponding to their vaccinal history (oral poliovirus and measles/mumps/rubella vaccine) and 2 to bocavirus and rhinovirus, which could suggest a temporal association with the disease. 57 Different studies have also found that an imbalance in the gut microbiota might interfere with the normal function of innate and adaptive immunity, and that variable microbiota interactions with environmental factors, mainly infectious agents, might drive the development of KD in a genetically susceptible child. 58 However, to date, no definite link has been irrefutably found between any viral agents and KD.

Conclusive Remarks. More than half a century after its discovery, it is frustrating to admit that KD is believed to be triggered by an infection, but that its direct unequivocal cause is unclear. Besides, at the age of 95, dr. Kawasaki remains very active and continues to support families with KD children through different nonprofit organizations. New theories about KD hypothesize that the disorder might be conceived as an autoinflammatory condition, 59 in which inflammation explodes without any involvement of autoimmune pathways and any sound relationship with microbial agents. [60] [61] [62] Although KD causal factors are still elusive, the available evidence indicates that the primum movens may be a dysregulation of immune responses to various infectious agents, i.e., a kind of immune-mediated "echo" induced also by a viral infection. Even if several data might suggest that KD is an infection-related clinical syndrome, which can develop only in children with a predisposing genetic background, our knowledge on both the infectious agents involved and genetic characteristics of susceptible children remains poor. Understanding the molecular players responsible for dysregulation of the immune response in KD will foster the development of improved predictive tools and a more rational use of therapeutic agents to decrease the risk of CAA in all children with KD.

In Memoriam. On June 5, 2020 dr. Tomisaku Kawasaki passed away at the age of 95: the news had a profound impact on many clinicians who dedicated their professional lives studying Kawasaki disease. He was a true model to all pediatricians, not only with regard to his clinical acumen but especially concerning his vibrant humanity. This article is sincerely dedicated to the memory of Tomisaku Kawasaki.

Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young

Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas

General pathology of Kawasaki disease on the morphological alterations corresponding to the clinical manifestations

Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study

Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I -definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II -treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome

Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome

Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study

The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age

The role of infection in Kawasaki syndrome

Non-infectious makers of Kawasaki syndrome: tangible or elusive triggers?

The epidemiology and pathogenesis of Kawasaki disease

Seasonality of Kawasaki disease: a global perspective

Seasonality in clinical courses of Kawasaki disease

Concurrent respiratory viruses and Kawasaki disease

Concomitant respiratory viral infections in children with Kawasaki disease

Infections and Kawasaki disease: implications for coronary artery outcome

Association of rotavirus infection with Kawasaki syndrome

Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection

Adenovirus type 2 isolated from a patient with fatal Kawasaki disease

Human adenovirus infection in Kawasaki disease: a confounding bystander

Clinical and virologic characteristics may aid distinction of acute adenovirus disease from Kawasaki disease with incidental adenovirus detection

Human herpesvirus 6 infection and Kawasaki disease

Isolation of human herpesvirus-6 from an infant with Kawasaki disease

Kawasaki disease associated with parvovirus B19 infection

Cytomegalovirus infection in a patient with atypical Kawasaki disease

Kawasaki disease with a concomitant primary Epstein-Barr virus infection

Recurrence of Kawasaki disease and Epstein-Barr virus infection

Kawasaki disease associated with measles virus infection in a monozygotic twin

Could a herpesvirus be the cause of Kawasaki disease?

Kawasaki disease associated with chickenpox: report of two sibling cases

Kawasaki disease coincident with influenza A H1N1/09 infection

Influenza infection and Kawasaki disease

Kawasaki syndrome and concurrent Coxsackie-virus B3 infection

Detection of human bocavirus in children with Kawasaki disease

Kawasaki disease and human bocavirus-potential association?

Markers of a recent bocavirus infection in children with Kawasaki disease: "a year prospective study

A novel variant of torque teno virus 7 identified in patients with Kawasaki disease

Kawasaki disease triggered by EBV virus in a child with familial Mediterranean fever

Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings

Influenza A (H1N1) pdm09 virus infection in a patient with incomplete Kawasaki disease: A case report

Viral infections associated with Kawasaki disease

Association between a novel human coronavirus and Kawasaki disease

Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome

Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease

COVID-19 and Kawasaki disease: novel virus and novel case

Incomplete Kawasaki Disease in a child with Covid-19

An outbreak of severe Kawasakilike disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Multisystem inflammatory syndrome in children in New York State

RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease

Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease

Identification of viral signatures using high-throughput sequencing on blood of patients with Kawasaki disease

The gut microbiota-host partnership as a potential driver of Kawasaki syndrome

How should we classify Kawasaki disease?

A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner

The broad-ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children

From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases